SecBot SecBot
8-K ·Filed Jun 4, 2026

ARAY

ACCURAY INC
NEUTRAL
Impact 3/10
Horizonimmediate Processed4mo ago SEC0001437749-26-019558
8-K material event: Items 1.02
Actionable Insight • Neutral

The scheduled debt repayment removes leverage and future interest costs, but the $18.3M cash outflow is significant relative to the $44M market cap. Watch the next 10-Q for cash position and any refinancing needs. No immediate catalyst for the stock.

DirectionNeutral
Confidencehigh
Horizonimmediate
Final — all horizons settled through T+60d
ARAY ▼ -23.08% at T+60d
NEUTRAL call -23.08% · α vs SPY -27.08% · entry $0.3419 → $0.2630
Entry = T+0 close
Jun 4, 2026
via day close
T+1d
+3.69%
call +3.69% · α +3.46%
$0.3545
settled 5mo ago
T+5d
-0.18%
call -0.18% · α -0.74%
$0.3413
settled 5mo ago
T+20d
-20.74%
call -20.74% · α -22.60%
$0.2710
settled 4mo ago
T+60d
-23.08%
call -23.08% · α -27.08%
$0.2630
settled 8w ago

Price Chart

Loading chart...

Executive Summary

Accuray repaid the remaining $18.0 million of its 3.75% Convertible Senior Notes due 2026 at maturity on June 1, 2026, along with $337,500 in accrued interest, fully satisfying and discharging the indenture. The repayment reduces debt and interest expense but uses cash, which may impact liquidity given the company's $44 million market cap.

Key Facts

  • Repaid $18,000,000 aggregate principal of 3.75% Convertible Senior Notes due 2026 on June 1, 2026.
  • Paid $337,500 in accrued and unpaid interest.
  • Notes were originally issued on May 13, 2021 and matured on June 1, 2026.
  • Indenture was satisfied and discharged; company released from remaining obligations.

Financial Impact

Repayment of $18.0 million in debt plus $337,500 in interest; debt removed from balance sheet, cash reduced by ~$18.3 million.

debtcashinterest expense

Risk Factors

  • Cash used for repayment may strain liquidity if cash reserves were limited.
  • No operating update provided; core business performance remains the key driver.

Market Snapshot

Exchange
Nasdaq
Sector
Surgical & Medical Instruments & Apparatus
Analyst Consensus
0% bullish (7 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001437749-26-019558
Document: 0001437749-26-019558-index-headers.html0001437749-26-019558
Document: 0001437749-26-019558-index.html0001437749-26-019558
Document: 0001437749-26-019558.txt0001437749-26-019558
16 reports for ARAY
Performance horizon
80% Hit rate @ T+5 4 of 5 directional calls Went positive at some point 5 of 5 best @ T+60▲ +54.08%Jul 31, 2026
Filters
Rows
Reports for ARAY — sortable, filterable
TypeNow
Oct 21, 2026
5d ago
Press Release
NEUTRAL ★ 1/10
$0.1340awaiting T+5—$0.1376 (+2.69%)
Oct 16, 2026
10d ago
DEF 14A
BEARISH ★ 6/10
$0.1400 $0.1250▲ +10.71%▲ +10.57%$0.1376 (+1.71%)
Oct 13, 2026
13d ago
8-K
NEUTRAL ★ 4/10
$0.1751 $0.1370▼ −21.76%▼ −22.21%$0.1376 (−21.42%)
Oct 7, 2026
19d ago
3
NEUTRAL ★ 2/10
$0.2414 $0.1738▼ −28.00%▼ −27.73%$0.1376 (−43.00%)
Oct 6, 2026
20d ago
8-K
BEARISH ★ 6/10
$0.2534 $0.1751▲ +30.90%▲ +29.92%$0.1376 (+45.70%)
Sep 27, 2026
4w ago
Press Release
NEUTRAL ★ 3/10
$0.2998 $0.3017▲ +0.63%▼ −0.57%$0.1376 (−54.10%)
Sep 22, 2026
5w ago
Institutional Cluster
MIXED ★ 3/10
$0.2300 $0.3000▲ +30.43%▲ +31.62%$0.1376 (−40.17%)
Sep 14, 2026
6w ago
EFFECT
BEARISH ★ 6/10
$0.2453 $0.2400▲ +2.16%▲ +2.27%$0.1376 (+43.91%)
Sep 11, 2026
6w ago
Press Release
NEUTRAL ★ 4/10
$0.2502 $0.2336▼ −6.63%▼ −6.41%$0.1376 (−45.00%)
Aug 19, 2026
9w ago
Press Release
BEARISH ★ 7/10
$0.2924 $0.2621▲ +10.36%▲ +11.48%$0.1376 (+52.94%)
Showing 10 of 16

US Market Status

Market Closed — Opens Wed (17h 28m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 4, 2026